Grepafloxacin Clinical Program for Lower Respiratory Tract Infections

The present paper evaluates the clinical trial program in lower respiratory tract infections treated with a new fluoroquinolone antibiotic, grepafloxacin. Unlike older quinolones, grepafloxacin has excellent activity against Gram-positive organisms, which include Streptococcus pneumoniae and “atypic...

Full description

Saved in:
Bibliographic Details
Main Author: Arne C Rodloff
Format: Article
Language:English
Published: Wiley 1998-01-01
Series:Canadian Journal of Infectious Diseases
Online Access:http://dx.doi.org/10.1155/1998/762368
Tags: Add Tag
No Tags, Be the first to tag this record!